While courts have struck down FDA's prohibition on off-label promotion based on First Amendment grounds, the agency has good standing to prohibit such actions when considering various canons of statutory construction, one law professor argues in a recently published University of Chicago Law Review article . FDA Commissioner Scott Gottlieb recently signaled FDA would rethink its approach toward off-label communication in light of recent court losses. While Gottlieb did not name cases, most proponents of off-label communication point to...